Early breast cancer
JR Benson, I Jatoi, M Keisch, FJ Esteva, A Makris… - The Lancet, 2009 - thelancet.com
Adoption of urbanised lifestyles together with changes in reproductive behaviour might
partly underlie the continued rise in worldwide incidence of breast cancer. Widespread …
partly underlie the continued rise in worldwide incidence of breast cancer. Widespread …
Tamoxifen for early breast cancer
G Early Breast Cancer Trialists' … - Cochrane Database …, 1996 - cochranelibrary.com
… But, in this analysis of early breast cancer among women with ER‐positive tumours, the
available PR measurements were of little additional value in predicting the response to tamoxifen…
available PR measurements were of little additional value in predicting the response to tamoxifen…
Polychemotherapy for early breast cancer: an overview of the randomised trials
Early Breast Cancer Trialists' Collaborative Group - The Lancet, 1998 - Elsevier
… with early breast cancer, … breast cancer, which has already been included in the analyses
of recurrence, and no apparent adverse effect on deaths from causes other than breast cancer (…
of recurrence, and no apparent adverse effect on deaths from causes other than breast cancer (…
[HTML][HTML] … the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer …
… The 2 years since the 2011 St Gallen Consensus [1] have seen substantial progress in
evidence relevant to various aspects of the treatment of early invasive breast cancer. The …
evidence relevant to various aspects of the treatment of early invasive breast cancer. The …
Follow-up of patients with early breast cancer
DF Hayes - New England Journal of Medicine, 2007 - Mass Medical Soc
… of invasive breast cancer in 2007. Improved screening and increased use of early local–…
breast cancer. Concerns about recurrence and the long-term complications of therapy in …
breast cancer. Concerns about recurrence and the long-term complications of therapy in …
Treatment of early breast cancer: a report after ten years of a clinical trial
H Atkins, JL Hayward, DJ Klugman, AB Wayte - Br Med J, 1972 - bmj.com
… Summary A controlled clinical trial has been carried out to compare radical mastectomy
with wide excision (extended tylectomy) in the treatment of early breast cancer. Only patients …
with wide excision (extended tylectomy) in the treatment of early breast cancer. Only patients …
Follow‐up strategies for women treated for early breast cancer
MPMP Rojas, E Telaro, I Moschetti… - Cochrane Database …, 2000 - cochranelibrary.com
… Follow‐up examinations are commonly performed after primary treatment for women with
breast cancer. They are used to detect recurrences at an early (asymptomatic) stage. …
breast cancer. They are used to detect recurrences at an early (asymptomatic) stage. …
[HTML][HTML] Prognostic molecular markers in early breast cancer
FJ Esteva, GN Hortobagyi - Breast cancer research, 2004 - Springer
… number of patients with early-stage breast cancer harbor microscopic metastasis at the time
… with early-stage breast cancer [1, 2]. Treatment options for early-stage breast cancer include …
… with early-stage breast cancer [1, 2]. Treatment options for early-stage breast cancer include …
Effects of radiotherapy and surgery in early breast cancer—an overview of the randomized trials
Early Breast Cancer Trialists' … - New England Journal …, 1995 - Mass Medical Soc
… treatments for early breast cancer (ie, breast cancer in … breast cancer had not recurred. This
overview of the trials compares the effects of these local therapies for early breast cancer on …
overview of the trials compares the effects of these local therapies for early breast cancer on …
Tamoxifen for early breast cancer: an overview of the randomised trials
Early Breast Cancer Trialists' Collaborative Group - The Lancet, 1998 - Elsevier
… But, in this analysis of early breast cancer among women with ER-positive tumours, the
available PR measurements were of little additional value in predicting the response to tamoxifen…
available PR measurements were of little additional value in predicting the response to tamoxifen…